Lannett To Present At The Canaccord Genuity 33rd Annual Growth Conference On August 15

Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Canaccord Genuity 33 rd Annual Growth Conference on Thursday, August 15, 2013, at 1:30 p.m. Eastern at the Intercontinental Boston Hotel.

Arthur Bedrosian, president and chief executive officer, will provide an overview of the company, and Martin Galvan, chief financial officer, will discuss the financials. The presentation will be available to interested parties through a live, listen-only audio web broadcast via the Internet at www.lannett.com. Listeners are encouraged to visit the web site at least 15 minutes prior to the start of the presentation to register, download and install any necessary audio software. The presentation will be archived and accessible on the web site for at least 90 days.

About Lannett Company, Inc.:

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company’s website at www.lannett.com.

Copyright Business Wire 2010

If you liked this article you might like

Lannett Scores FDA OK for Nexium Generic-Biotech Movers

Teva, Mylan Seen to Stay on M&A Sidelines

Teva's Massive Debt Load Just Became an Even Bigger Issue

Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers